Glutamate imaging better than MR spectroscopy in first three hours after ischemic stroke

Glutamate imaging reveals ischemic lesions in the first 3 hours after stroke that are not distinguishable in T1-weighted and T2-weighted imaging.

Researchers using chemical exchange saturation transfer (CEST), an emerging MRI technology, have found that using glutamate with CEST shows in vivo. The finding has the potential to speed diagnosis—and, therefore, treatment—in the critical first hours after a stroke.

"I have been interested in glutamate imaging since its inception," said researcher Zhuozhi Dai of Second Affiliated Hospital of Shantou University Medical College, Shantou, China. "Being able to evaluate glutamate in the brain could be of great benefit in the clinical setting."


Explore further

Peritoneal dialysis as an intervention for stroke patients

More information: Dr. Dai presented the study on Monday, May 5 at the 2014 ARRS Annual Meeting in San Diego, CA.
Citation: Glutamate imaging better than MR spectroscopy in first three hours after ischemic stroke (2014, May 7) retrieved 17 July 2019 from https://medicalxpress.com/news/2014-05-glutamate-imaging-spectroscopy-hours-ischemic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more